EMA (EU)
EVENT
Committee for Medicinal Products for Human Use (CHMP): 18-21 May 2026
Published: 5/18/2026Detected: 5/8/2026
Summary preview
Schedules the CHMP plenary meeting to be held 18–21 May 2026 at the European Medicines Agency (Amsterdam) and reiterates CHMP’s role in preparing Agency opinions for human medicines.
Get the full analysis, free
Create a free account to see the complete summary, key takeaways, and why this matters for your products, and to get alerts like this by email.
Create free accountmanufacturing
quality
clinical
safety
labeling
#CHMP
#European Medicines Agency
#human medicines
#committee meeting
#opinion
Official Source Document Source Verified
Access the original document directly from EMA.
More from EMA (EU)
- Mandatory use of ISO/ICH E2B(R3) individual case safety reporting in the EU: hands-on training course using the EudraVigilance system10/12/2026
- First European Medicines Agency (EMA) - International Society for Cell and Gene Therapy (ISCT) bilateral meeting10/12/2026
- Q&A clinic on eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) service - October 202610/8/2026
- PMS Q&A Clinic on Product User Interface (PUI) and Application Programming Interface (API) – October 202610/8/2026
- SPOR and XEVMPD status update webinar - Q4 202610/7/2026